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Abstract
Background/Purpose In a multi-project research line, we
are currently testing whether a morphologically and func-
tionally near normal epidermis can be cultured from human
sweat gland (SG) cells and be used as a skin substitute. The
present study focuses on the stratum corneum of the epi-
dermis that assumes a vital barrier function for the skin.
The main process in the formation of the cornified cell
envelope in human epidermis, i.e. crosslinking of proteins
and lipids, is catalyzed by several transglutaminases (TG).
Therefore, we compared the expression patterns of various
TG and their substrates in SG-derived versus keratinocyte-
derived epidermal substitutes.
Methods Sweat gland cells, keratinocytes, and fibroblasts
were isolated from human skin samples and cultivated
separately to generate epidermal substitutes. These were
transplanted onto the back of athymic rats. After 2 weeks,
the transplants were excised and analyzed histologically as
well as by indirect immunofluorescence. We looked at the
expression of TG1, 3, 5, and their substrates involucrin and
loricrin (=markers of epidermal differentiation) in SG-
derived and keratinocyte-derived skin substitutes as well as
in normal skin.
Results The SG cell-derived epidermis was near normal
anatomically, formed a cornified cell envelope and dem-
onstrated TG1, 3, and 5 as well as involucrin and loricrin
expression patterns similar to those found in keratinocyte-
derived epidermis and normal control skin.
Conclusion These findings support the thesis that SG
cells have the potential to form a near normal stratified
epidermal analog that might be used as a skin substitute.
The expression of TG1 and 3, not normally expressed in
human SG, suggests the presence of re-programmed SG
cells and/or stem cells capable of both de novo generating
and maintaining an epidermis.
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Introduction
Burn surgeons as well as plastic and reconstructive sur-
geons are still facing considerable difficulties when mas-
sive skin defects must be covered. No doubt, one of the
most recent and promising strategies to overcome this
problem is the engineering of skin. Today, cultured epi-
thelial autografts as well as a variety of composite skin
substitutes are readily available in many centers. However,
the use of cultured skin substitutes is still associated with
problems such as poor take, the melting graft phenomenon,
and severe scarring, all of which continue to plague
patients and clinicians alike [1–6]; and clearly, none of the
above laboratory products has the fabulous properties of
natural (full thickness) skin grafts. Therefore, our tissue
engineering efforts aim at building a skin analog in the
laboratory that architecturally and functionally closely
approximates normal skin.
One of our projects looks at the question whether SG
cells can transdifferentiate into epidermal keratinocytes,
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or, whether human SG actually contain stem cells that
can produce keratinocytes. We could in fact demonstrate
that a stratified and cornified epidermis can be cultured
from human SG cells and then be successfully trans-
planted onto immunoincompetent rats (manuscript in
preparation).
One of the crucial tasks of the epidermis is its barrier
function, mainly provided by the keratinocytes’ capability
to form the so-called cornified cell envelope, a protein and
lipid containing layer synthesized and deposited directly
beneath the plasma membrane. The enzymes TG1, 3, and 5
are the driving force behind the formation of the cornified
cell envelope, which is an essential element of epidermal
differentiation. They catalyze covalent c-glutamyl-e-lysine
crosslinks between extracellular matrix proteins [7]. The
substrate involucrin is crosslinked by TG and serves as a
scaffold for further crosslinkings to form the cornified cell
envelope [8–10]. Loricrin, another TG-substrate, is the
main component (70%) of the cornified cell envelope and
is stored in the granules of the stratum granulosum [11, 12].
TG1 is the only TG anchored in the plasma membrane of
keratinocytes. It is expressed in the stratum spinosum and
granulosum [13]. TG3 is expressed in the upper stratum
granulosum and is found in the cytosol of keratinocytes
[14]. TG5 is mainly expressed early during epidermal
differentiation and identified in the stratum spinosum and
granulosum, to a lesser extent also in the basal layer
(perinuclear area of keratinocytes) [15].
The goal of this study is to compare TG1, 3, and 5, as
well as their substrates involucrin and loricrin in SG-
derived and keratinocyte-derived epidermis. Because these
molecules are critically involved in the formation of the
cornified cell envelope, they are viewed as markers of
epidermal differentiation.
Materials and methods
Human skin specimens
Following the approval by the ethics committee of the
Canton of Zurich and after written informed consent by
parents and/or patients, skin samples from scalp, abdomen,
retroauricular area, or foreskins were obtained from
patients aged between 1 and 18 years. The specimens were
used for isolation of SG cells, keratinocytes, and fibro-
blasts, or employed for histological analysis.
Cell cultures
Keratinocytes and fibroblasts were isolated and cultured
according to standard protocols as described earlier [16].
For SG cells, we used the following procedure:
The day before isolation, mitomycin-treated or irradi-
ated swiss albino 3T3 mouse fibroblasts (ATCC CCL-92)
were seeded at a density of 10,000 per cm2 in DMEM, 10%
calf serum, and 5 lg/ml gentamycin. Immediately before
plating the fragments of sweat glands (SGs), the medium
was changed to the original Rheinwald and Green medium
(RGM) [17, 18].
Skin samples were cut into small pieces (*6 mm2),
digested in DMEM containing 12 U/ml dispase (Invitro-
gen, Basel, Switzerland), 2 mg/ml collagenase blend F
(Sigma, Buchs, Switzerland), and 38 U/ml collagenase II
(Worthington, Bioconcept, Allschwil, Switzerland) for
16 h at 4C and 4 h at 37C until the mesenchyme was
almost completely digested. Tissue pieces were centrifuged
and fat droplets removed with the supernatant. The pellet
was re-suspended in 20 ml of DMEM containing threefold
concentrated antibiotics (gentamycin 15 lg/ml, penicillin
3,000 U/ml, streptomycin 3 mg/ml, and fungizone 750 ng/
ml), 1% FCS, and transferred to a new culture dish. The
dermis was then separated from the epidermis and SG
fragments were collected using a stereomicroscope and
micropipettes. The fragments were washed with culture
medium and finally transferred to the culture dish. After 4–
5 days, the first outgrowing cells were visible. After
2 weeks, the feeder cells were removed by digestion with
0.1% trypsin, 1 mM EDTA (Invitrogen, Basel, Switzer-
land) for 2 min at 37C. The remaining SG cells were
washed twice in PBS and detached from the dish with 0.5%
trypsin, 5 mM EDTA, for 5 min at 37C. Trypsin activity
was stopped by the addition of 3.75 mg/ml soy bean
trypsin inhibitor (Invitrogen, Basel, Switzerland). An
almost single cell suspension was achieved by repeated
pipetting.
Keratinocytes and SG cells were further expanded dur-
ing the first passage. Keratinocytes were grown in a serum-
free medium (SFM, Invitrogen, containing 0.2 ng/ml EGF
and 25 lg/ml bovine pituitary extract). SG cells were
maintained in RGM.
Construction of dermo-epidermal substitutes
Substitutes were produced using a previously established
transwell system consisting of six-well cell culture inserts
with membranes of 3.0-lm pore-size (BD Falcon, Basel,
Switzerland) [16]. Briefly, membranes were covered with
rat tail collagen type I hydrogels (3.2–3.4 mg/ml, BD
Biosciences, Allschwil Switzerland) containing human
dermal fibroblasts (passage 1). The collagen matrix was
prepared according to the protocol of Costea et al. [18].
These dermal equivalents were grown in DMEM/10% FCS
for 5 days. Subsequently, SG cells and keratinocytes were
separately seeded onto dermal equivalents at a density of
125 9 103 cells per cm2 within siliconized polypropylene
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rings of 5 mm in diameter to avoid dispersion. After 7 h,
the rings were removed, 1 ml RGM was added in the upper
chamber, and 2 ml were added to the lower chamber.
Triplicate wells were set-up for each dermo-epidermal
substitute. The constructs were cultured in RGM. After
4 days, the dermo-epidermal substitutes were raised to the
air/liquid interface and cultured for three additional weeks.
Transplantation of cultured dermo-epidermal
substitutes
Dermo-epidermal grafts were transplanted onto full thick-
ness skin defects created surgically and encased by poly-
propylene rings (27-mm diameter) as previously described
[16]. Rings were sutured on the back of 10-week-old
female athymic Nu/Nu rats. Transplants were covered with
a silicon foil. After 14 days, grafts were excised and pro-
cessed for cryo- and paraffin sections. Isoflurane (Abbott
AG, Baar, Switzerland) was used as anesthetic in all
procedures.
Histology and immunofluorescence
Excised specimens were embedded in OCT compound
(Sakura Finetek/Digitana AG, Horgen, Switzerland) and
frozen at -20C. Cryosections were fixed and permeabi-
lized in acetone for 5 min at -20C, air-dried, washed
three times in PBS, and blocked in PBS, containing 2%
BSA (Sigma, Buchs, Switzerland), for 30 min. Incubation
with diluted antibodies was performed in blocking buffer
for 1 h at room temperature. Slides were washed three
times for 5 min in PBS and blocked for additional 15 min
before the second antibody was added. If necessary, the
same procedure was repeated for the third antibody incu-
bation. Finally, slides were incubated for 5 min in PBS
containing 1 lg/ml Hoechst 33342 (Sigma, Buchs, Swit-
zerland), washed twice for 5 min in PBS, and mounted
with Dako mounting solution (Dako, Baar, Switzerland)
containing 25 mg/ml of DABCO anti-quenching agent
(Sigma, Buchs, Switzerland).
Antibodies
For immunofluorescence, the following antibodies were
used: From LabVision (P.H.Stehelin&CIE AG, Basel,
Switzerland): Involucrin (clone SY5, 1:100); from Abcam
(Cambridge, UK): Loricrin (polyclonal, 1:500); from Novus
Biologicals (Littleton, CO, USA): transglutaminase 1
(polyclonal, 1:800), transglutaminase 3 (polyclonal, 1:50),
transglutaminase 5 (polyclonal, 1:200). As a secondary
antibody, we used FITC-conjugated polyclonal goat F(ab0)2
fragments directed to mouse immunoglobulins (Dako, Baar,
Switzerland). For double IF, some of the primary antibodies
were pre-labeled with Alexa 555-conjugated polyclonal
goat F(ab0)2 fragments, according to the instructions of the
manufacturer (Zenon Mouse IgG Labeling Kit, Molecular
Probes, Invitrogen, Basel, Switzerland).
Results
A keratinocyte-derived substitute and an SG-derived sub-
stitute are shown in Fig. 1a, b. Basically, in both the sub-
stitutes, all epidermal layers are present: the basal layer,
6–8 suprabasal layers, and a well-differentiated stratum
corneum. In certain areas, the SG-derived epidermis is less
compact or appears somewhat disorganized, while in other
areas, there is almost no difference to natural epidermis
discernable.
An overview of expression patterns of TG1, 3, 5, as well
as involucrin and loricrin in normal skin, SG, SG-derived,
and keratinocyte-derived skin substitutes is given in
Table 1. In the global picture, SG and keratinocyte-derived
skin substitutes phenomenologically demonstrated staining
patterns identical to those of normal skin (control). How-
ever, there were certain quantitative and site-related dif-
ferences, which are described below in more detail.
In SG, TG1 (Fig. 1c) and 3 were not expressed, while
TG5 (Fig. 1d) expression was found in ductal as well as
secretory glandular cells.
In normal skin (=control), TG1 stained positive in the
upper stratum spinosum and stratum granulosum with
membrane-bound distribution (Fig. 2a). An almost identi-
cal pattern was found in SG-derived (here with a slightly
more extended weak staining into the lower part of the
stratum spinosum) (Fig. 3a) and keratinocyte-derived skin
substitutes.
In normal skin, TG3 stained positive in the stratum
granulosum (upper layers) and corneum (Fig. 2b). A
basically identical picture was obtained in keratinocyte-
derived skin. In the SG-derived epidermis, all epidermal
layers stained positive for TG3 with a cytoplasmic distri-
bution of the enzyme (Fig. 3b).
In normal skin, TG5 was detected in the stratum
spinosum, granulosum, and basale with a perinuclear,
intracellular distribution (Fig. 2c). In keratinocyte-derived
epidermis, there was a strong positivity for TG5 in all
layers with a maximum in the basal layer (perinuclear
distribution). The SG-derived substitutes showed an iden-
tical TG5 expression pattern as normal skin, with the
strongest staining in the basal layer and upper stratum
granulosum (Fig. 3c).
In normal skin, involucrin was present in the stratum
granulosum and corneum (Fig. 2d). The substitutes derived
from keratinocytes and SG cells (Fig. 3d) stained all
suprabasal layers positive, whereas the basal layers were
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negative. Involucrin distribution was identified along cell
membranes with a fine granular staining in the cytoplasm.
In normal skin, loricrin was detected in the upper stra-
tum granulosum and, to a lesser extent, in the stratum
corneum. A similar staining is present in the epidermal
substitutes. Loricrin stained identical in both substitutes,
but it was markedly stronger than in control skin.
Discussion
The focus of the present study was to look at how SG-
derived epidermal substitutes compared with keratinocyte-
derived epidermal substitutes and normal skin (serving as
control) in terms of epidermal differentiation, particularly
the formation of the stratum corneum.
As a first step, epidermal substitutes using SG cells or
keratinocytes were grown in culture, then transplanted onto
immunoincompetent rats, harvested 2 weeks thereafter,
and finally analyzed histologically with particular regard to
established markers for epidermal differentiation (TG1, 3,
5 as well as involucrin and loricrin).
In general, both SG and keratinocyte-derived skin sub-
stitutes exhibited a near normal epidermal architecture with
a basal layer, a correct number of suprabasal cell layers,
and a well-developed stratum corneum. The fact that both
substitutes survived for 2 weeks on an animal, moreover,
indicates that the near natural epidermal anatomy also
provided sufficient function, particularly barrier function.
However, the key findings of this experiment are the
astoundingly similar expression patterns of both substitutes
and normal skin with regard to the epidermal differentia-
tion markers tested. The following points deserve a
comment:
First, TG1, 3, and 5, all present in normal skin, were also
identified in both epidermal substitutes. Although this is
rather to be expected for keratinocyte-derived skin, it
represents a striking finding for the SG-derived substitute,
since in human SG, only TG5 can be identified. It is rea-
sonable to assume that SG cells cultured to form an epi-
dermal equivalent may undergo a re-programming process
Fig. 1 a Epidermal substitute
derived from keratinocytes
(between arrows), 14 days after
transplantation on an athymic
rat, hematoxylin and eosin,
940. b Epidermal substitute
derived from SG cells (between
arrows), 14 days after
transplantation on an athymic
rat, hematoxylin and eosin,
940. c Normal human skin.
Sweat gland, glandular part
(framed by dashed line), TG1
negative (green), fluorescence
microscopy 940. d Normal
human skin. Sweat gland,
glandular part (framed by
dashed line), TG5 positive
(green), fluorescence
microscopy 940
Table 1 Overview of relative expression patterns of markers com-
pared with normal human skin (Nhs)
Nhs SGnhs Esdk EsdSG
TG1 ? - ? ??
TG3 ? - ? ???
TG5 ? ? ??? ?
Involucrin ? ±a ??? ???
Loricrin ? - ?? ??
Nhs Normal human skin, SGnhs sweat gland in normal human skin,
Esdk epidermal substitute derived from keratinocytes, EsdSG epi-
dermal substitute derived from SG cells
a Negative in the glandular part, positive in the ductal part of sweat
glands
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allowing TG1 and 3 expressions again. Alternatively, stem
cells, present in the culture, might promote expression of
those enzymes crucial for the formation of the cornified
cell envelope. It is noteworthy in this context that Brouard
has suggested that human SGs might harbor epidermal
stem cells [19].
Fig. 2 a Normal human skin.
Stratum spinosum and
granulosum (between arrows),
TG1 positive (green), confocal
microscopy 940. b Normal
human skin. Stratum
granulosum and corneum
(between arrows), TG3 positive
(green), confocal microscopy
940. The remaining areas with
seemingly positive signals are
background signals. c Normal
human skin. Stratum basale,
spinosum, and granulosum
(between arrows), TG5 positive
(green), confocal microscopy
940. d Normal human skin.
Stratum granulosum and
corneum (between arrows),
involucrin positive (red),
fluorescence microscopy 940
Fig. 3 a Epidermal substitute
derived from SG cells. Stratum
spinosum and granulosum
(between arrows), TG1 positive
(green), fluorescence
microscopy 940. b Epidermal
substitute derived from SG
cells. Stratum basale, spinosum,
granulosum, and corneum
(between arrows), TG3 positive
(green), fluorescence
microscopy 940. c Epidermal
substitute derived from SG
cells. Stratum basale, spinosum,
and granulosum (between
arrows), TG5 positive (green),
fluorescence microscopy 940.
d Epidermal substitute derived
from SG cells. Stratum
spinosum, granulosum, and
corneum (between arrows),
involucrin positive (red),
fluorescence microscopy 940
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The second aspect regards some distinct TG staining
differences between the skin substitutes and control skin.
Although TG1 and 5 expression was virtually identical in
SG derived and control skin, TG3 stained positive in all
layers of SG-derived skin, but only in the stratum granu-
losum of normal skin. In contrast, in keratinocyte-derived
skin the TG1 and 3 patterns were the same as in control
skin, while TG5 stained positive in all layers, whereas it
was only found in the stratum spinosum and granulosum of
control skin. These differences can be viewed as a (par-
tially) delayed epidermal differentiation. This explanation
appears particularly plausible for SG cell-derived skin, as
here, a probably intricate transition from ductal or secre-
tory glandular cells to interfollicular epidermal keratino-
cytes must be accomplished. The literature does not offer
any direct corroboration for our thesis. On the other hand,
Inada et al. [20] showed that under wound healing condi-
tions, TG1 was initially expressed in all suprabasal layers,
whereas later on, in a homeostatic situation, TG1 was only
found in the stratum spinosum and granulosum. Therefore,
it is conceivable that, analogously, TG3 (in SG-derived
skin) and TG5 (in keratinocyte-derived skin) are upregu-
lated early after transplantation. Of note, wound healing
studies investigating regulation and expression of TG3 and
5 do not exist.
Thirdly, we showed that involucrin and loricrin were
expressed in both skin substitutes (of note, these molecules
are not identifiable in SG). This is an important confir-
mation that epidermal differentiation also takes place with
regard to TG substrates, which are the key components of
the cornified cell envelope indispensable for epidermal
barrier function [7–12]. Here, again, we found an impres-
sive overexpression of involucrin that parallels the one
identified on the enzyme level, indicating that homeostasis
is not yet reached, i.e. terminal differentiation is not yet
accomplished. Interestingly, Stark et al. [21] reports that
involucrin is often upregulated in vitro. This might be an
alternative explication for the mentioned overexpression.
In contrast, loricrin was similarly expressed in both sub-
stitutes and control skin.
In conclusion, we demonstrated that an epidermis can be
cultured from human SG cells and be successfully trans-
planted as a skin substitute. The near normal expression of
epidermal differentiation markers, especially TG1 and 3,
not normally expressed in human SG, suggests the pres-
ence of re-programmed SG cells, and or stem cells capable
of both de novo generating and maintaining an epidermis.
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